Cardiex Ltd
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more
Cardiex Ltd (CDX) - Net Assets
Latest net assets as of December 2024: AU$6.60 Million AUD
Based on the latest financial reports, Cardiex Ltd (CDX) has net assets worth AU$6.60 Million AUD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$16.99 Million) and total liabilities (AU$10.39 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$6.60 Million |
| % of Total Assets | 38.86% |
| Annual Growth Rate | 7.74% |
| 5-Year Change | -30.49% |
| 10-Year Change | -5.69% |
| Growth Volatility | 160.83 |
Cardiex Ltd - Net Assets Trend (2002–2024)
This chart illustrates how Cardiex Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cardiex Ltd (2002–2024)
The table below shows the annual net assets of Cardiex Ltd from 2002 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | AU$4.09 Million | +508.43% |
| 2023-06-30 | AU$-1.00 Million | -115.14% |
| 2022-06-30 | AU$6.61 Million | -16.42% |
| 2021-06-30 | AU$7.91 Million | +34.53% |
| 2020-06-30 | AU$5.88 Million | -15.41% |
| 2019-06-30 | AU$6.95 Million | +51.23% |
| 2018-06-30 | AU$4.60 Million | +245.97% |
| 2017-06-30 | AU$1.33 Million | -57.70% |
| 2016-06-30 | AU$3.14 Million | -27.53% |
| 2015-06-30 | AU$4.33 Million | +31.98% |
| 2014-06-30 | AU$3.28 Million | -32.69% |
| 2013-06-30 | AU$4.88 Million | +158.91% |
| 2012-06-30 | AU$1.88 Million | -37.85% |
| 2011-06-30 | AU$3.03 Million | -18.86% |
| 2010-06-30 | AU$3.74 Million | -19.55% |
| 2009-06-30 | AU$4.65 Million | -22.08% |
| 2008-06-30 | AU$5.96 Million | -36.46% |
| 2007-06-30 | AU$9.38 Million | -34.87% |
| 2006-06-30 | AU$14.41 Million | -23.35% |
| 2005-06-30 | AU$18.80 Million | +669.34% |
| 2004-06-30 | AU$2.44 Million | +131.56% |
| 2003-06-30 | AU$1.05 Million | +33.21% |
| 2002-06-30 | AU$792.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cardiex Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 8669069000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$88.11 Million | 2155.57% |
| Other Comprehensive Income | AU$2.67 Million | 65.32% |
| Total Equity | AU$4.09 Million | 100.00% |
Cardiex Ltd Competitors by Market Cap
The table below lists competitors of Cardiex Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Oronova Energy Inc
V:ONV-H
|
$4.25 Million |
|
Indo Acidatama Tbk
JK:SRSN
|
$4.25 Million |
|
Mynaric AG
PINK:MOYFF
|
$4.25 Million |
|
Lendway Inc.
NASDAQ:LDWY
|
$4.25 Million |
|
Pursuit Minerals Ltd
AU:PUR
|
$4.25 Million |
|
Ace Oldfields PT
JK:KUAS
|
$4.25 Million |
|
Praxis Home Retail Limited
NSE:PRAXIS
|
$4.24 Million |
|
Anghami De Inc
NASDAQ:ANGH
|
$4.24 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cardiex Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -1,000,771 to 4,087,481, a change of 5,088,252.
- Net loss of 6,765,365 reduced equity.
- Share repurchases of 673,039 reduced equity.
- New share issuances of 8,000,000 increased equity.
- Other comprehensive income decreased equity by 3,473,574.
- Other factors increased equity by 8,000,230.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-6.77 Million | -165.51% |
| Share Repurchases | AU$673.04K | -16.47% |
| Share Issuances | AU$8.00 Million | +195.72% |
| Other Comprehensive Income | AU$-3.47 Million | -84.98% |
| Other Changes | AU$8.00 Million | +195.73% |
| Total Change | AU$- | % |
Book Value vs Market Value Analysis
This analysis compares Cardiex Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.67x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.02x to 1.67x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-06-30 | AU$1.82 | AU$0.03 | x |
| 2006-06-30 | AU$1.65 | AU$0.03 | x |
| 2007-06-30 | AU$0.91 | AU$0.03 | x |
| 2008-06-30 | AU$0.58 | AU$0.03 | x |
| 2009-06-30 | AU$0.45 | AU$0.03 | x |
| 2010-06-30 | AU$0.36 | AU$0.03 | x |
| 2011-06-30 | AU$0.24 | AU$0.03 | x |
| 2012-06-30 | AU$0.14 | AU$0.03 | x |
| 2013-06-30 | AU$0.31 | AU$0.03 | x |
| 2014-06-30 | AU$0.21 | AU$0.03 | x |
| 2015-06-30 | AU$0.26 | AU$0.03 | x |
| 2016-06-30 | AU$0.15 | AU$0.03 | x |
| 2017-06-30 | AU$0.06 | AU$0.03 | x |
| 2018-06-30 | AU$0.16 | AU$0.03 | x |
| 2019-06-30 | AU$0.10 | AU$0.03 | x |
| 2020-06-30 | AU$0.07 | AU$0.03 | x |
| 2021-06-30 | AU$0.08 | AU$0.03 | x |
| 2022-06-30 | AU$0.06 | AU$0.03 | x |
| 2023-06-30 | AU$-0.01 | AU$0.03 | x |
| 2024-06-30 | AU$0.02 | AU$0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cardiex Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -165.51%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -62.04%
- • Asset Turnover: 0.86x
- • Equity Multiplier: 3.09x
- Recent ROE (-165.51%) is below the historical average (-77.42%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | -14.34% | -86.80% | 0.15x | 1.08x | AU$-4.58 Million |
| 2006 | -27.80% | -120.13% | 0.21x | 1.10x | AU$-5.45 Million |
| 2007 | -55.24% | -106.34% | 0.43x | 1.22x | AU$-6.12 Million |
| 2008 | -63.62% | -58.80% | 0.81x | 1.33x | AU$-4.39 Million |
| 2009 | -36.41% | -15.09% | 1.42x | 1.70x | AU$-2.16 Million |
| 2010 | -32.65% | -13.26% | 1.56x | 1.58x | AU$-1.59 Million |
| 2011 | -101.61% | -41.31% | 1.42x | 1.73x | AU$-3.38 Million |
| 2012 | -105.36% | -30.82% | 1.54x | 2.22x | AU$-2.17 Million |
| 2013 | 56.04% | 30.19% | 1.42x | 1.31x | AU$2.25 Million |
| 2014 | -81.11% | -52.71% | 1.09x | 1.41x | AU$-2.99 Million |
| 2015 | -33.23% | -26.34% | 0.92x | 1.37x | AU$-1.87 Million |
| 2016 | -153.02% | -95.75% | 1.09x | 1.47x | AU$-5.12 Million |
| 2017 | -328.46% | -100.84% | 1.46x | 2.23x | AU$-4.50 Million |
| 2018 | -64.43% | -73.92% | 0.62x | 1.40x | AU$-3.42 Million |
| 2019 | -42.86% | -76.25% | 0.30x | 1.90x | AU$-3.67 Million |
| 2020 | -56.47% | -77.35% | 0.40x | 1.82x | AU$-3.91 Million |
| 2021 | -70.11% | -110.89% | 0.44x | 1.42x | AU$-6.34 Million |
| 2022 | -172.18% | -279.90% | 0.33x | 1.87x | AU$-12.04 Million |
| 2023 | 0.00% | -414.03% | 0.32x | 0.00x | AU$-18.96 Million |
| 2024 | -165.51% | -62.04% | 0.86x | 3.09x | AU$-7.17 Million |
Industry Comparison
This section compares Cardiex Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $16,052,969
- Average return on equity (ROE) among peers: -338.92%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cardiex Ltd (CDX) | AU$6.60 Million | -14.34% | 1.57x | $4.25 Million |
| 4DMEDICAL Ltd (4DX) | $926.64K | -85.93% | 0.18x | $1.03 Billion |
| Adherium Ltd (ADR) | $34.53 Million | -3.63% | 0.08x | $2.37 Million |
| Aroa Biosurgery Ltd (ARX) | $-22.65 Million | 0.00% | 0.00x | $92.74 Million |
| Atomo Diagnostics Ltd (AT1) | $34.48 Million | -26.73% | 0.05x | $8.96 Million |
| Control Bionics Ltd (CBL) | $6.09 Million | -15.97% | 0.04x | $4.98 Million |
| Compumedics Ltd (CMP) | $9.21 Million | -30.70% | 1.16x | $13.08 Million |
| Cochlear Ltd (COH) | $75.42 Million | 53.19% | 1.13x | $7.01 Billion |
| Cleo Diagnostics Ltd (COV) | $5.83 Million | -68.54% | 0.19x | $23.47 Million |
| Conneqt Health Limited (CQT) | $633.50K | -2871.98% | 13.72x | $4.66 Million |